Enfusion, Inc.

Technology
Computer Software: Prepackaged Software
www.enfusion.com

Earnings Score
Moat Score

Market Cap $949.07M
PE 285
Debt $NaN
Cash $48.30M
EV $NaN
FCF $31.77M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	$3.33M
EBIT	$7.07M
ROE	3%
ROA	5%
FCF	$31.77M
Equity	$96.18M
Growth Stability	1
PE	285.44
PEG	179.53
PB	9.87
P/FCF	29.87
P/S	4.86
Price/Cash	0.05
Net Margins	2%
Gross Margins	67%
Op. Margins	4%
Earnings CAGR	2%
Sales Growth YoY	15%
Sales Growth QoQ	3%
Sales CAGR	23%
FCF CAGR	20%
Equity CAGR	310%
Earnings Stability	-0.84
Earnings Growth YoY	-23%

Earnings Growth QoQ	-31%
Earnings CAGR 5Y	2%
Sales CAGR 5Y	23%
FCF CAGR 5Y	20%
Equity CAGR 5Y	310%
Earnings CAGR 3Y	21%
Sales CAGR 3Y	21%
FCF CAGR 3Y	106%
Equity CAGR 3Y	-7%
Market Cap	$949.07M
Revenue	$195.16M
Assets	$134.94M
Cash	$48.30M
Shares Outstanding	91.3M
Earnings Score	6%
Moat Score	52%
Working Capital	61.87M
Current Ratio	3.62
Gross Profit	$131.06M
Shares Growth 3y	4%
Equity Growth QoQ	8%
Equity Growth YoY	31%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.

SEC Filings

Direct access to Enfusion, Inc. (ENFN) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Enfusion, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Enfusion, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 2%

Stability -84%

loading chart...

Enfusion, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Enfusion, Inc..

Years

Calculation mode

= $1.3B

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$32M	$38M	$46M	$56M	$67M	$81M	$97M	$117M	$141M	$170M	$205M	$2.1B
DCF		$35M	$38M	$42M	$46M	$50M	$55M	$60M	$66M	$72M	$79M	$790M
Value	$1.3B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	21%	5%	-253%	-9%	3%	2%
ROA	-	-	-260%	-10%	11%	5%
ROE	-	-	-290%	-13%	8%	3%

Bad Net Margins (1.82%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-	-	-	-	-
Debt over Equity	-	-0.44	-	-	-	-
Growth Stability	-	-	-	-	-	1

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Neutral Debt/Equity ratio (-)

The company has a balance between equity and debt that is not too good nor too bad.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2019	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	35%	40%	35%	16%	23%
Earnings YoY growth	-	-68%	-7K%	-95%	-145%	2%
Equity YoY growth	-	98%	-142%	6%	-25%	310%
FCF YoY growth	-	-143%	145%	-175%	240%	20%